VSIR and myeloproliferative neoplasm: Specifically, VISTA expression levels were notably higher, with mean percentages reaching 23.97% for G-MDSCs and 31.56% for M-MDSCs in MPN patients, both showing statistically significant differences compared to healthy controls.